Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis - Pathophysiological and diagnostic clues

Cytokine

Volumn 12, Issue 6, 2000, Pages 822-827

  Westerholt, Sören ^a   Hartung, Thomas ^b   Tollens, Martin ^a   Güstrau, Andrea ^a   Oberhoffer, Mathias ^c   Karch, Helge ^d   Klare, Bernd ^a   Pfeffer, Klaus ^a   Emmrich, Peter ^a   Oberhoffer, Renate ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Enterohaemorrhagic E. coli; Haemolytic uremic syndrome; Interleukin 8; Interleukin 10; Neopterin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; NEOPTERIN;

ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROENTERITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNE RESPONSE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 17444433029     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0624     Document Type: Article

References (15)

1. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157:H7, other Enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 13:1991;60-98.
2. Obrig TG. Pathogenesis of shiga toxin (verotoxin)-induced endothelial cell injury. Kaplan BS, Trompeter RS, Moake JL. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. 1992;405-419 Marcel Dekker, Inc. New York.
3. Louise CB, Obrig TG. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of shiga toxin, interleukin-1β, tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun. 59:1991;4173-4179.
4. Kaye SA, Louise CB, Boyd B, Lingwood A, Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1β_ enhancement of shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun. 61:1993;3886-3891.
5. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int. 42:1992;951-956.
6. Yamada S, Matsushita S, Kai A, Sasaki M, Tsuji A, Kanemitsu T, Yamashita N, Anzai E, Kudoh Y. Detection of verotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157:H7. Microbiol Immunol. 37:1993;111-118.
7. Lopez EL, Contrini MM, Devoto S, de Rosa MF, Grana MG, Genero MH, Canepa C, Gomez HF, Cleary TG. Tumor necrosis factor concentrations in hemolytic uremic syndrome patients and children with bloody diarrhea in Argentina. Pediatr Infect Dis J. 14:1995;594-598.
8. Walters MDS, Matthei IU, Kay R, Dillon MJ, Barratt TM. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol. 3:1989;130-134.
9. Milford DV, Staten J, MacGreggor I, Dawes J, Taylor CM, Hill FG. Prognostic markers in diarrhea-associated haemolytic-uraemic syndrome: initial neutrophil count, human neutrophil elastase and von Willebrand factor antigen. Nephrol Dial Transplant. 6:1991;232-237.
10. van de Kar NCAJ, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VWM, Monnens LA. Plasma cytokine levels in hemolytic uremic syndrome. Nephron. 71:1995;309-313.
11. Pradier O, Gerard C, Delvaux A. Interleukin-10 inhibits the induction of monocyte procoagulent activity by bacterial lipopolysaccharide. Eur J Immunol. 23:1993;2700-2703.
12. Kobayashi M, Wada H, Wakita Y. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 73:1995;10-14.
13. Murata A, Shimazu T, Yamamoto T. Profiles of circulating inflammatory- and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E-coli O157 infection. Cytokine. 10:1998;544-548.
14. Westendorp RG, Langermans JA, Huizinga TW. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 349:1997;170-173.
15. Center of Disease Control, 1997, Hemolytic Uremic Syndrome, Post-diarrheal, http://www.cdc.gov/epo/mmwr/other/case_def/hus97.html.